Subscribe for the newsletter
Mobile Navigation
Subscribe for the Newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Ironshore Pharmacueticals
Sort By
Newest First
1 / 1
1 / 1
Sign in
FDA Approval
Ironshore Pharmaceuticals Announces FDA Approval of JORNAY PMTM(Methylphenidate) Extended-Release Capsules CII for the Treatment of ADHD
Ironshore Pharmaceuticals
PR-M08-18-NI-101
Aug 27, 2018
